Wednesday, 13 September 2017

Amicus Therapeutics' wound treatment fails late-stage trial

(Reuters) - U.S. drug developer Amicus Therapeutics Inc said on Wednesday its drug to treat wounds failed to meet the main goals of a late-stage clinical trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)